J Korean Soc Emerg Med.  2014 Dec;25(6):771-774. 10.0000/jksem.2014.25.6.771.

The Experience and Management of Two Cases of Metformin-associated Lactic Acidosis

Affiliations
  • 1Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Korea. kwangpmc@daum.net

Abstract

Metformin, a dimethylbiguanide, is an oral antihyperglycemic drug used in treatment of type 2 diabetes mellitus. It has been reported that metformin may be associated with lactic acidosis in patients with clinical conditions such as renal failure and heart failure. Metformin-associated lactic acidosis (MALA) is a rare, but serious complication with a mortality rate of approximately 30~50%. Therefore, an aggressive treatment strategy including hemodialysis is recommended for these patients. Although continuous renal replacement therapy (CRRT) has been administered in hemodynamically unstable patients with MALA, there are few case reports describing the use of CRRT as a therapeutic modality in Korea. Here, we describe the case histories of two MALA patients who underwent treatment with CRRT.

Keyword

Metformin; Acidosis; Lactic; Renal replacement therapy

MeSH Terms

Acidosis
Acidosis, Lactic*
Diabetes Mellitus, Type 2
Heart Failure
Humans
Korea
Metformin
Mortality
Renal Dialysis
Renal Insufficiency
Renal Replacement Therapy
Metformin
Full Text Links
  • JKSEM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr